These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2887988)

  • 1. [Immunologic tumor markers].
    von Kleist S
    Lebensversicher Med; 1987 Jul; 39(4):100-2. PubMed ID: 2887988
    [No Abstract]   [Full Text] [Related]  

  • 2. Current condition and prognosis of tumor immunotherapy: a second opinion.
    Mastrangelo MJ; Berd D; Maguire HC
    Cancer Treat Rep; 1984 Jan; 68(1):207-19. PubMed ID: 6362864
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoperoxidase staining in tumor marker distribution studies in cytologic specimen.
    Coleman DV; To A; Ormerod MG; Dearnaley DP
    Acta Cytol; 1981; 25(3):205-6. PubMed ID: 7020314
    [No Abstract]   [Full Text] [Related]  

  • 4. [Surface markers of blood lymphocytes in cancer patients with special reference to natural killer cells].
    Utsunomiya A
    Igaku Kenkyu; 1987 Sep; 57(5):284-300. PubMed ID: 3448874
    [No Abstract]   [Full Text] [Related]  

  • 5. [Surface antigens of human neoplasias].
    Pfreundschuh M
    Fortschr Med; 1986 May; 104(19):389-93. PubMed ID: 2424814
    [No Abstract]   [Full Text] [Related]  

  • 6. What's new in tumor markers and their measurements?
    von Kleist S
    Pathol Res Pract; 1988 Feb; 183(1):95-9. PubMed ID: 2452433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavior of ABH surface antigens in superficial and invasive bladder neoplasma: inferences for the mechanism of tumor progression].
    Srougi M; Alves VA; Gayotto LC; Arap S
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(1):24-7. PubMed ID: 3547591
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnosis of tumors with the use of immunologic tumor markers].
    Vorlaender KO
    Wien Med Wochenschr; 1983 Feb; 133(3):59-66. PubMed ID: 6189301
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunologic diagnosis of cancer--tumor markers].
    Kawai T
    Gan No Rinsho; 1989 Jan; Spec No():13-8. PubMed ID: 2915470
    [No Abstract]   [Full Text] [Related]  

  • 10. [The importance of immunohistochemistry in histological diagnosis].
    Hurlimann J
    Rev Med Suisse Romande; 1990 Jul; 110(7):597-602. PubMed ID: 2382067
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tumor markers].
    Hattori N
    Gan No Rinsho; 1986 Aug; 32(10):1059-64. PubMed ID: 3537355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic markers for acute leukemia: a morphologist's perspective.
    Brunning RD; McKenna RW
    Monogr Pathol; 1987; (29):124-60. PubMed ID: 3295518
    [No Abstract]   [Full Text] [Related]  

  • 13. [Present and future of tumor markers].
    Kawai T
    Rinsho Byori; 1987 Feb; 35(2):167-71. PubMed ID: 3586352
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cell receptors and tumor markers].
    Verh Dtsch Ges Pathol; 1986; 70():1-691. PubMed ID: 3030017
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunological diagnosis of malignant diseases outside the lymphoreticular system].
    Wiig JN
    Tidsskr Nor Laegeforen; 1978 Sep; 98(25):1197-1200. PubMed ID: 358487
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor markers of the central nervous system.
    Birkmayer GD
    Cancer Detect Prev; 1981; 4(1-4):231-8. PubMed ID: 7349780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple cell markers in bladder cancer. Principles and clinical applications.
    Javadpour N
    Urol Clin North Am; 1984 Nov; 11(4):609-16. PubMed ID: 6390912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
    Forti E; Wolf D; Melia M
    Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
    [No Abstract]   [Full Text] [Related]  

  • 19. [Conservation or loss of membrane antigens of the ABH blood group and their precursor substance. Prognostic importance for tumors of the bladder].
    Hammou JC; Fella C; Vacant J
    Acta Urol Belg; 1983; 51(1):12-7. PubMed ID: 6858793
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)].
    Gelabert Mas A; Corominas J; Arango O
    Actas Urol Esp; 1988; 12(3):248-53. PubMed ID: 3177059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.